Best treatments for breast neoplasms

Understanding breast neoplasms

Breast cancer is a disease in which cells in the breast grow out of control. According to the American Cancer Society, it usually begins in the milk ducts (ductal cancers) or the milk-producing lobules (lobular cancers). The American Cancer Society also explains that breast cancer can be non-invasive (in situ), meaning it has not grown into deeper breast tissue, or invasive, meaning it has spread into surrounding tissue. MedlinePlus notes that possible signs include a new lump or thickening in or near the breast or armpit, a change in breast size or shape, skin dimpling or puckering, a nipple turned inward, nipple discharge other than breast milk, or scaly, red, or swollen skin around the nipple or breast. Breast cancer may also be found before symptoms appear; the National Cancer Institute states that mammograms can detect breast cancer early, possibly before it has spread. MedlinePlus describes that a breast biopsy is used to diagnose breast cancer, and that doctors test the tumor for hormone (estrogen and progesterone) receptors and HER2 status to help guide care. This is general information, not medical advice.

Frequently asked

What treats breast neoplasms?

Our catalog lists 91 products that may treat breast neoplasms, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is exemestane.

What is the best-rated treatment for breast neoplasms?

By our independent recall-safety rating — not an efficacy measure — exemestane ranks highest among the products we list for breast neoplasms. Always consult a professional.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat breast neoplasms?

Treatments for breast neoplasms span FDA drug classes including aromatase inhibitor, anthracycline topoisomerase inhibitor, nucleoside metabolic inhibitor, androgen, estrogen. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.